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Human pluripotent stem cells can be differentiated into cardiomyocytes in vitro. 
Differentiated cardiomyocytes are at an important role in the future clinical applications 
of treating cardiac diseases. The purpose of this study was to optimize the 
cardiomyocyte differentiation of human pluripotent stem cells using four different 
culture media and to characterize the differentiated cardiomyocytes.  The aim of the 
study was to find a best suited culture medium for cardiomyocyte differentiation. 
 
Human embryonic stem cell line H7 and two induced pluripotent stem cell lines, h1/12 
and 0/gG/25 were differentiated, and on day 22 the beating areas were counted. 
Cardiomyocytes were characterized by evaluating the beating rate and morphology, 
with immunocytochemical stainings and quantitative polymerase chain reaction (q-
PCR).  
 
The results show only small differences in the amount of beating areas acquired with 
each medium. 0% KO-SR hes medium gave the best result whereas the smallest amount 
of beating areas was acquired with Reges medium. The analysis with q-PCR showed 
positive gene expression of stem cell markers and high expression of cardiac markers in 
the differentiated cardiomyocytes with each tested medium and cell line. The highest 
gene expression in cardiomyocytes was observed in day 30 samples grown in 0%-
medium. 
 
According to the results, the best medium for the cardimyocyte differentiation would be 
0% KO-SR hes medium. However, this medium should be studied even further with 
more different cell lines. Considering the q-PCR results, it would be interesting to study 
cardiomyocytes even older than 30 days, which are differentiated in 0% KO-SR 
medium.  
 
 
 
 
 
 
 
 
 
 
_______________________________________________________________ 
Keywords: cardiomyocyte differentiation, stem cell, induced pluripotent stem cell, 
culture media, characterization, polymerase chain reaction 
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1 INTRODUCTION 
 
Stem cell research is one of the fastest growing and very promising field of research in 
natural sciences. Due to stem cell’s potential to differentiate into any cell types, they 
make an excellent subject for medical research especially in regenerative medicine. 
With the introduction of induced pluripotent stem cells (iPSC) from human somatic 
fibroblasts, the possibilities for clinical usage of stem cells grew rapidly. Already 
nowadays stem cells are being differentiated into for example neural, mesenchymal and 
cardiac cells for research purposes. Nowadays with the massive increase in heart 
diseases, a great point of interest lies in the clinical exploitation of cardiomyocytes 
differentiated from iPS cells. 
 
Cardiomyocytes cannot regenerate from cell damage after myocardial infarction. Being 
able to replace those damaged cells with cardiomyocytes differentiated from stem cells 
acquired from the patient would be a huge step forward in medical technology. So far 
cardiomyocytes have been differentiated as multicellular aggregates in vitro, but in the 
future it may be possible to grow new heart tissue. This bachelors thesis focuses on 
optimizing the growth media used in the differentiation of cardiomyocytes in vitro. 
 
This bachelors thesis was done at the heart research group in Regea Institute for 
Regenerative Medicine. Regea is a joint institute under the administration of University 
of Tampere. The research there primarily focuses on stem cells and tissue engineering. 
 
The purpose of this study was to test different cell culture media in the cardiac 
differentiation of pluripotent stem cells. In this study four different cell culture media 
were used and three different cell lines, two of which were iPS cell lines. Three of these 
cell culture media had not been used previously in Regea. One point of interest was to 
see whether the cell culture media used would affect embryonic stem cells and iPS cells 
differently. The aim of this study was to find a cell culture medium best suited for 
differentiation of cardiomyocytes, so that it could be used in the heart group of Regea 
for future research.  
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2 BACKGROUND 
 
 
2.1 Stem cells 
 
Stem cells are undifferentiated cells that have the ability to self-renew indefinitely in 
culture and are capable of differentiation. Human stem cells can be classified into four 
different groups: embryonic- (hESC), fetal-, adult- and induced pluripotent stem cells 
(iPS cells). HESCs are isolated from inner cell mass of surplus embryos obtained from 
fertilization treatments First hESC line was derived in 1998. (Thomson & Co 1998.) 
Adult stem cells are responsible for tissue regeneration and fetal stem cells are involved 
in the growth of organs in the developing fetus. Adult and fetal stem cells can 
differentiate only into some specific cell types, thus they are called multipotent. HESCs 
and iPS cells are pluripotent stem cells, meaning that they can differentiate into almost 
any cell type, excluding extra embryonic tissue and the placenta. Because of their ability 
to differentiate into various cell types, stem cells are currently one the most studied 
subjects in molecular biology. (Passier & Mummery 2003.) 
  
The derivation of hESC line is carried out by first removing the zona pellucida and 
trophoblast from 5-7 days old blastocyst. The remaining inner cell mass is transferred to 
mitotically inactivated feeder cells, normally human foreskin fibroblasts (figure 1). 
After transfer the cells are cultured in culture medium containing growth factors and 
nutrients for the cells. However, because the feeder cells are derived from primary 
tissue, their lifespan is relatively short and that is why the feeder cell layer has to be 
replaced regularly. (Unger & Co 2009.) 
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FIGURE 1. The derivation of human embryonic stem cells (figure modified from 
Vaajasaari 2010). 
 
Pluripotent stem cells express certain genes which maintain them in an undifferentiated 
state. Such markers are OCT3/4 (also called POU5F1), Nanog, Sox2 and FoxD3, for 
example. Oct3/4, a transcription factor gene is especially highly expressed in stem cells. 
Identifying these markers from cells under research confirms them as stem cells. 
(Sperger & Co 2003.) 
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2.2 Induced pluripotent stem cells (iPSC) 
 
iPS cells are the newest discovery in the field of regenerative medicine. iPS cells are 
derived from somatic cells that are genetically reprogrammed, or induced, into a 
pluripotent state. By inducing the somatic cells with specific genes, they are forced to 
express genes and factors that make them return to stem cell-like state. iPS cells have 
been found to express stem cell markers and to differentiate into cells of all three germ 
layers: ectoderm, mesoderm and endoderm. First iPS cells were derived from mouse 
fibroblasts in 2006 and a year later, from adult human fibroblasts. (Takahashi & Co 
2007.) 
 
Generating iPS cell lines requires four transcription factor genes: OCT3/4, Sox2, Klf4 
and c-Myc. This combination was described by Doctor Yamanaka in 2007. These 
exogenous genes are delivered virally to fibroblasts and the cells are grown on hESC 
culture conditions. This will cause the fibroblasts to transform into iPS cells, which are 
very similar to hESCs in morphology, proliferation and gene expression (figure 2). The 
differentiation capacity seems to be similar to hESCs. (Freund & Mummery 2009.) 
 
 
FIGURE 2. The induction of  iPS cells from human adult fibroblasts (figure modified 
from Lahti 2010) 
iPS cells 
Skin 
fibroblasts 
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 With iPS cell technology it is possible to create patient-specific stem cell lines with a 
rare disease for example. This will provide cells for future therapy without the need for 
immune suppression and it will also give the scientists a new way to study stem cells 
carrying disease traits. (Freund & Mummery 2009.) 
 
 
2.3 Stem cell culture 
 
Culturing of human stem cells is a very delicate process and prone to contamination, 
like any other cell culture. The goal of stem cell culturing is to keep the cells alive and 
in an undifferentiated state. The common way of culturing stem cells is to use feeder 
cells. Feeder cells secrete growth factors that induce the proliferation of stem cells and 
prevent differentiation. To be useable, feeder cells have to be inactivated with 
irradiation or with a treatment with mitomycin C to stop them from dividing. In this 
study, mitotically inactivated mouse embryonic fibroblast cells (MEFs) were used as 
feeder cells. (Allele Biotechnology 2010.) Mitomycin C is a strong antibiotic with 
antitumor activity against various types of mouse, rat, hamster and also human cancers. 
Mitomycin C also prevents the synthesis of DNA in bacteria and cultured human cells 
but not the synthesis of RNA or protein translation. This ensures cell growth but 
prevents cell division. (Kuroda  & Furuyama 1963.) 
 
Cells are cultured in gelatin coated well plates to ensure their attachment to the bottom 
of the well. Feeder cells are plated at least one day before transferring stem cells on top 
of feeders. Stem cells grow and fill the well typically within a week, thus making it a 
necessity to divide stem cells once a week. The medium normally used for 
undifferentiated stem cells is called KSR medium. KSR is a serum free medium which 
contains 20% knockout serum replacement and bFGF growth factor. (Inzunza & Co 
2004.) 
 
Fetal bovine serum (FBS) is extracted from the blood of bovine fetuses and has been 
used for a long time in cell culture. The fact that the serum comes from animals makes it 
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unsuitable in future clinical applications of cardiac cells, but it is still a widely used 
ingredient in stem cell research. (Jochems & Co 2002.) FBS is used in cell culture 
because it contains many growth factors and very little antibodies.  These growth factors 
in FBS enhance the differentiation of stem cells which is the reason that FBS has been 
replaced in the culture of undifferentiated stem cells. There are also studies that suggest 
better cardiac differentiation in serum free cultures compared to cells grown in culture 
containing 20% or less FBS. (Passier & Co 2005.) 
 
Knockout serum replacement (KO-SR) is a serum free formulation, designed to replace 
the FBS as a supportative factor in the growth of undifferentiated stem cells. Stem cells 
grown in KO-SR enhanced media are discovered to differentiate much less and to grow 
better than cells grown in FBS enhanced media. Using a serum-free supplement also 
minimizes the risk of pathogen and foreign animal protein contaminations in medium. 
(Inzuza & Co 2004.) 
 
 
2.4 Cardiomyocytes 
 
Cardiomyocytes are the main cell type of myocardium tissue. Although not the most 
numerous, they cover over 90% of the myocardium volume. Cardiomyocytes are 
continuously contracting muscle cells and almost completely dependent on aerobic 
metabolism, which is why they contain almost 25% mitochondria of the total cell 
volume. The contractile unit in cardiomyocyte is the sarcomere, which consists of 
myosin and actin filaments and regulatory proteins like troponin and tropomysin. 
Cardiomyocytes comprise about 25% of the total cells in heart, the rest are endothelial 
cells like fibroblasts and cells constructing the myocardial capillary system. There are 
different kinds of cardiomyocytes: atrial, ventricular and nodal. Atrial myocytes are 
located in the atrium where blood is collected and ventricular myocytes in the ventricle, 
from where the blood is pushed out of heart. Cardiomyocytes contain also much of 
sarcoplastic reticulum, a special form of smooth endoplastic reticulum, which function 
is to store and release Ca
2+
-ions needed during muscle contraction. (Humpath.com  
2010.) 
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2.4.1 Differentiation of cardiomyocytes 
 
During early embryogenesis the endoderm is known to affect greatly in the cardiac 
differentiation of the precursors in the adjacent mesoderm. When this fact was 
discovered, two different approaches for the differentiation of cardiomyocytes from 
hESCs were developed. The first one was a co-culture with mouse visceral endoderm-
like cells (END-2). END-2 cells produce cardio-inductive signals to hESCs cells. The 
signaling is thought to originate from cell-to-cell interactions and/or certain stimulating 
factors secreted by END-2 cells, but the effects of END-2 cells in cardiac differentiation 
are indisputable. (Vidarsson, Hyllner & Sartipy  2010.) 
 
The second method for differentiation was addition of hormones and growth factors 
directly to hESCs grown as multicellular aggregates called embryoid bodies or in a 
monolayer fashion. Stem cells require also certain growth factors to remain in an 
undifferentiated state. Such growth factors are basic fibroblast growth bFGF and activin 
a, for example. The interesting part about these growth factors is that some of them also 
enhance differentiation of stem cells, with the right concentration and timing in the 
culture medium. With the removal and alteration of concentrations of such factors from 
culture medium and implication of differentiation enhancing growth factors, researchers 
can differentiate stem cells practically into any desired cell type. (Singla & Burton 
2005.)  
 
 
2.4.2 Growth factors 
 
Growth factors enhancing cardiac differentiation can be classified into three major 
families of growth factors: the transforming growth factor (TGF) -family, the Wnt 
family and fibroblast growth factor family (FGF). (Vidarsson, Hyllner & Sartipy 2010). 
TGF--family includes bone morphogenic proteins (BMPs) and activin. BMPs have an 
important role in early embryogenesis and induction of cell differentiation. Activin-A is 
a protein that stimulates the release of follicle stimulating hormone and it has wide 
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variety of biological activities, most important ones being mesoderm induction and cell 
differentiation. (R&D Systems 2001.) 
 
Wnts are secreted glycoproteins that are important in the development of Drosophila, 
but Wnt11 protein has also been found to increase cardiac gene marker expression in 
cell cultures treated with Wnt11 conditioned medium. (Singla & Burton 2005.) 
 
Fibroblast growth factors are polypeptides from a family of cytokines comprising of 23 
members. All of those molecules interact with FGF receptors and that complex is 
involved in many biological activities, including embryonic development, cell migration 
and tumor growth. FGF2 has been found to increase cardiac differentiation in hESCs. 
(Singla & Burton 2005.) 
 
 
2.5 Characterization of cardiomyocytes 
 
 
2.5.1 Gene expression of cardiomyocytes 
 
Cardiac cells express certain genes unique to them, which allows the identification of 
cardiomyocytes with some molecular biology techniques. Such genes are Troponin T, a 
part of tropomyosin complex which works with actinin in heart muscle cells, MYH7, 
which codes for the production of myosin heavy chain protein (Megy & Co. 2002.), 
Nkx2,5 a gene required for cardiac development in vertebrate animals, which is most 
active in early cardiac progenitor cells (Schwartz & Olson 1999.) or ISL1, a 
transcription factor required for the development of complete heart in the cardiac 
mesoderm. (Cai & Co 2003.) 
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2.5.2 Immunocytochemical staining 
 
Immunocytochemical staining is a basic biochemical method to visualize a specific 
protein or even tissue in a sample using fluorescently labeled antibodies. Antibodies, or 
immunoglobulins, are glycoproteins found in blood that recognize and neutralize 
foreign objects. Antibodies bind to their specific target molecule, called the antigen. 
Antigens are the locations in samples that are points of interest in immunocytochemical 
staining procedure. When antibodies bind to their target site the desired target can be 
observed with a fluorescence microscope. (Campbell & Farrel 2008, 417-423.) 
 
There are two possible ways to use antibodies in immunocytochemical staining: single 
staining with only one antibody or double staining with two different antibodies. In 
double staining the primary antibody binds to the target site in the sample after which 
the fluorescently labeled secondary antibody is added. Secondary antibodies are 
targeted against the primary antibodies, which allow them to bind to the primaries. The 
staining color comes from fluorescent secondary antibodies. The antibodies are 
produced in different animals like mouse, rabbit, donkey and goat. The secondary 
antibodies are always produced in different animals than primary ones. For example if 
the primary antibody is rabbit IgG, a common antibody, the secondary antibody should 
be anti-rabbit IgG and cannot be produced in a rabbit. (IHCWORLD 2007.) 
 
 
2.5.3 Polymerase chain reaction 
 
Polymerase chain reaction, PCR for short, is a technique used to efficiently amplify a 
desired DNA sequence. The DNA sequence to be amplified can be any desired 
sequence of the sample DNA. PCR reaction amplifies DNA exponentially with the help 
of nucleotides, primers and thermostable polymerase enzymes. The primers are short 
segments of DNA with the known amino acid order and polymerase enzymes were 
found from archae in hot springs and other extreme locations and are still in use today. 
Commonly used polymerase is Taq-polymerase, derived from Thermus aquaticus, a 
bacterium living in hot springs. (Campbell & Farrel 2008, 386-388.) 
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For the PCR reaction a master mix solution is prepared. Master mix contains all the 
necessary ingredients for the reaction. Those are buffer solution, nucleotide mixture, 
called the dNTP mix, polymerase enzyme, water as solvent, RNase inhibitor and the 
assay. The assay is the primer for the gene of interest. The master mix is added in 
excess to all samples so that the wanted gene can multiply exponentially. (Campbell & 
Farrel 2008, 386-388.) 
 
PCR consists of three stages: denaturation, annealing and extension. In denaturation 
stage the temperature is raised to +94°C for few minutes. This causes the DNA strands 
to denature and separate from each other. In the annealing step the temperature is 
lowered to about 55°C where the specifically designed primers bind to their 
complementary places in the template DNA. Last step is extension where nucleotides 
start to add to the growing 3’ end of DNA strand starting from the primer. One PCR 
cycle consists of these three stages and once there has been enough cycles, there is 
enough of the desired DNA material. Normally 25-35 cycles are enough to produce a 
satisfying amount of DNA. Figure 3 visualizes the exponential amplification of the 
target gene in the sample. At the end of PCR cycles the DNA yield can be measured 
with gel electrophoresis, for example. (Campbell & Farrel 2008, 386-388.) 
 
FIGURE 3. Polymerase chain reaction, amplification of the target gene (Haponen 2010) 
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2.5.4 Quantitative polymerase chain reaction 
 
Quantitative PCR (q-PCR) is also called real time- PCR because the rate of reaction can 
be followed in real time. Q-PCR uses fluorescent probes to detect the amount of target 
sample. The probes can be non-specific or specific, in which case more than one sample 
can be studied simultaneously. Fluorescence markers bind to multiplied DNA segments 
and emit fluorescence once bound. (Wilson & Walker 2005.) 
 
The most commonly used non-specific marker is SYBR Green I. It is a dye that binds to 
double stranded DNA and emits fluorescence at 520nm. The intensity of fluorescence is 
proportional to the amount of DNA in which the dye can bind to. Therefore an increase 
in fluorescence is observed after each cycle. SYBR markers use normally two primers: 
forward and reverse primers. Forward primer starts to build DNA strand from the 
beginning of the target sequence and reverse primer starts from the end of the sequence 
and codes the addition of nucleotides backwards. (Wilson & Walker 2005.) 
 
For specific quantification there are double-dye probes called TaqMan probes. These 
probes are small nucleotide sequences complementary to one of the strands of desired 
DNA, the amplicon. TaqMan probes contain a fluorophore and a quencher at 5’ end 
which prevents emission from the fluorophore. Once the probe binds to DNA and 
polymerase starts to build a new DNA strand, the 5’end of probe is degraded and the 
quencher is released in the solution thus allowing the fluorophore to emit fluorescence, 
which is also proportional to the amount to DNA amplified. (Eurogentec 2010.) 
 
To identify the DNA products after the amplification, a dissociation curve analysis 
technique can be used. This technique adds a dissociation stage after the PCR 
amplification cycles. Dissociation stage consists of three stages as seen in table 1. 
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TABLE 1. Dissociation curve analysis stages 
Temperature 95°C 60°C 95°C 
Time 15 sec 1 min 15 sec 
 
The dissociation temperature of the amplified product gives a DNA melting curve, 
which expresses the GC/AT ratio of DNA and length of DNA strand. This gives 
information about the sequence of the DNA strand and with this information undesired 
PCR products can be distinguished from target products. This removes the need to run 
gel electrophoresis after PCR run. (Ririe & Co 1997.) 
 
After the q-PCR run the results are analyzed using the relative quantification of gene 
expression data and the 2
- Δ ΔC
T-method as described by Livak and Schmittgen (2001, 
402-408.)  This method relates to the PCR signal of the target sample to a reference 
sample called the housekeeping gene. This allows the visualization of relative changes 
in gene expression between different samples. The housekeeping genes are called 
RPLP0 for TaqMan assays and PPIG for SYBR assays.  
 
 
2.5.5 Reverse transcription PCR 
 
Sometimes the sample is composed of RNA instead of DNA. In that case a 
complementary DNA copy has to be made out of sample RNA. This is done using 
reverse transcriptase enzyme. Reverse transcriptase is obtained from viruses and it 
functions as a RNA dependant DNA polymerase. Once the RNA has been transcribed, 
the PCR or q-PCR reaction can be carried out normally. (Campbell & Farrel 2008, 384-
386.) 
 
 
15 
 
3 THE PURPOSE AND AIM OF THE STUDY 
 
The purpose of this bachelor’s thesis was to test four different cell culture media in the 
cardiac differentiation of pluripotent stem cells and to characterize the differentiated 
cardiomyocytes. The characterization was carried out by calculating the beating 
cardiomyocyte areas from the culture wells and by evaluating their morphology and 
beating rate. The identification of heart muscle cells and especially ventricular heart 
muscle cells from other cells was done by immunocytochemical staining. The 
expression of genetic cardiac markers from the cardiomyocytes was characterized with 
quantitative polymerase chain reaction.  
 
The aim of the study was to find a best suited cell culture medium for cardiomyocyte 
differentiation. So far the heart group in Regea has used 10%-KO-SR medium for 
cardiac differentiation. Along with the old medium, three other media were used, two of 
which were serum free and one xeno-free. The optimal differentiation medium would 
produce a good percentage of beating areas with a healthy rate of beating and the cells 
expressing all the wanted cardiac gene markers. The aim of the study was also to find 
cheaper medium for cardiac differentiation in Regea, to ease the reagent costs in 
research.  
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4 MATERIALS AND METHODS 
 
 
4.1 Cell lines used in study 
 
In this study three different cell lines were used: a commercial human embryonic stem 
cell line H7, one patient iPS cell line called 0/gG/25 and a iPS cell line derived from 
neonatal fibroblasts called h1/12. 0/gG/25 cell line is derived from the skin fibroblasts 
of a patient with a known disease. The effects of those diseases are not included in this 
project though. H7 is a commercial cell line used as a control in Regea and in many 
other institutes. 
 
 
4.2 Culture media used in study  
 
This study was carried out using four different cardiac differentiation media: 0% KO-
SR hes, 10% KO-SR hes, EB-medium and Reges (Appendix 1). All the media contain 
the same basic ingredients with minor alterations in quantities. 0%- medium is relatively 
plain medium with just base Knockout DMEM medium and some obligatory 
supplements which are listed in table 2. Normally ascorbic acid is added to 0%-medium, 
but it was left out in this study. This medium is completely serum- and serum 
replacement free. 10% KO-SR contains 10% knockout serum replacement supplement. 
This is the medium currently in use in Regea’s heart group. EB-medium contains 20% 
FBS which makes it unsuitable in future clinical applications of cardiac cells, but it is 
still an important ingredient in stem cell research.  
 
The most interesting medium to be tested is the Reges medium, which is entirely 
developed in Regea institute. Reges is a serum- and xeno-free medium which means it 
contains nothing extracted from animals and thus could be used with cells for clinical 
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applications. Although the same is true for 0% hes-media, it is interesting to see how 
this newly developed medium works. The components of Reges are very similar to 10% 
KO-SR, with some differences shown in the table 2. KO-SR contains all the 
components in the reagent table listed in appendix 1, except bFGF, Activin-A and 
Retinol and the other components used in every media. 
 
TABLE 2. Reagent differences in the four test media 
Reagent 0 % 10 % EB Reges
KO-DMEM x x x x
KO-SR x
FBS x
NEAA x x x x
Glutamax x x x x
Pen/Strep x x x x
b-mercaptoethanol x x x
bFGF x
Activin a x
Retinol x
Other Reges components x  
 
4.3 Differentiation procedure 
 
To differentiate stem cells into cardiomyocytes the cells were transferred into 12-well 
plates which already contained END-2 cells. From the 6-well plates where the stem 
cells were growing on, the MEF layer was removed and the remaining cells were 
scraped from the bottom. Then about 30 cell flakes per well were pipetted onto END-2 
cells in 12-plates. Prior to cell transfer the END-2 plates had been filled with 0% KO-
SR hes-medium with ascorbic acid.  
 
Cells were incubated in 0% KO-SR hes-medium for 15 days with medium changes at 
day 6, 9, and 12. At day 15 the new test media was replaced onto the cell plates. After 
day 15 the medium was changed 3 times a week. The differentiation procedure was 
done from two different passages of each cell line.  
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4.3.1 Identification and evaluation of beating areas 
 
Cells were monitored at day 22 from the start of differentiation and beating areas were 
counted and their morphology evaluated using a regular light microscope and a heating 
plate. A beating area on the plate is an aggregate of cardiac cells differentiated from 
stem cells. The size, shape and location of beating area may vary even between cells of 
the same line and with the same growth medium. The cells were observed using a 4 
times magnification of the microscope.  
 
 
4.3.2 Dissociation of beating areas 
 
On day 23 beating areas of cardiomyocytes were cut manually with a sterile scalpel. 
The beating areas were transferred into one well in 24-well plate in their own culture 
medium. After that the beating areas were dissociated in three dissociation buffers 
(appendix 2).  The buffers are called 1, 2 and 3, and the incubation time was 30min, 
45min and 1h, respectively. Incubations 1 and 3 were carried out in room temperature 
and incubation 2 in +37°C incubator. After the third incubation the cells were 
transferred to EB medium and pipetted up and down to break the cell clumps into single 
cells. The cell solution from each medium was divided into four wells and EB medium 
was added to the total volume of 1ml. The dissociated cells were left to attach and grow 
in an incubator for 5-7 days after which they were used for immunocytochemical 
staining.  
 
 
4.4 Immunocytochemical staining 
 
In this study a double staining technique was used and the three pairs of primary 
antibodies were: Connexin-43 + -Actinin, ventricular MHC + Troponin T and 
Troponin T + Vimentin. Connexin-43 binds to muscle cells and -Actinin binds to thin 
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filaments in striated muscle cell called the Z discs. (Young & Co 1998.) Connexin-43 
also connects to Ca
2+
-channels in muscle cells (Heino & Vuento 2004, 292). Ventricular 
MHC stands for myocin heavy chain, a protein in heart and skeletal muscle responsible 
for motor actions. MHC antibody binds to ventricular muscle cells. (Kolossov & Co 
2005.)  Troponin T binds to heart muscle cells and Vimentin binds to every other cell 
types. (R&D Systems 2010.) 
 
Immunocytochemical staining was done from dissociated cells according to the figure 4, 
which illustrates the process. Table 3 lists the reagents used in the protocol to clarify the 
picture. On the plate were 4 wells for each test medium and three pairs of antibodies, so 
one set of wells was a spare. Antibodies were added to wells in the following order: 
Connexin + Actinin, MHC + Troponin T and Vimentin + Troponin T, and the well 
numbers were 1, 2 & 3, respectively. The corresponding secondary antibodies were 
added after primary antibodies were incubated overnight.  List of primary and 
secondary antibodies and their dilutions are listed in the appendix 3. Vectashield 
mounting medium was added at the end of procedure to help retaining fluorescence and 
to give anti-fading ability to the fluorescent colours. Vectashield also contains DAPI 
counterstain, which stains the nucleus of the cells. (Vector Laboratories 2010) 
 
TABLE 3. Reagents used in the double fluorescence protocol 
Abbreviation Reagent 
PBS 
Phosphate buffered 
saline 
PFA Paraformaldehyde 
BSA 
Bovine Serum 
Albumine 
NDS Normal Donkey Serum 
PB Phosphate buffer 
 
In table 4 are listed the contents of different solutions used. 
TABLE 4 Solutions for immunocytochemical staining 
Blocking solution 10% NDS, 01% Triton-X, 1% BSA 
Primary mix 1% NDS, 0,1% Triton-X, 1% BSA + antibodies 
Secondary mic 1% BSA in PBS + antibodies 
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2x PBS
5min
4% PFA
20min
2x PBS
5min
3x 1% BSA in PBS
5-7min
Mix of seconday 
antibodies
3x PBS 
5min
Blocking
45min RT
Wash with
Primary mix
Primary antibodies
O/N +4C
2x PB
5min
Vectashield +
coverslips
Storage +4C
Light protected
FIGURE 4. Scheme of  immunocytochemical staining procedure 
 
The secondary antibodies were fluorescent on different wavelengths, so when observed 
with a fluorescence microscopy, differently coloured antibodies could be visualized by 
changing the wavelength of the light source. Cells were observed with 20x 
magnification, and the pictures taken were piled together with computer software to 
acquire an image with three different colours.  
 
 
4.5 RNA extraction  
 
RNA samples were taken from the differentiated cardiomyocytes on days 0, 13, 22 and 
30. For the samples two random wells from a 12-well plate were scraped with a cell 
scraper and washed once with phosphate buffered saline, PBS. The cells were 
transferred to an eppendorf tube and the cell debris was spinned down. PBS was sucked 
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out and 350µl of RA1 buffer was added to lyse the samples. The samples were stored in 
-80°C until RNA extraction was carried out.  
 
For the extraction of RNA from the sample, a commercial Cytospin kit was used. 
According to manufacturer’s protocol, the samples were filtered with a centrifuge and 
filter membrane, bound to RNA columns and desalted with membrane desalting buffer. 
The DNA was removed enzymatically with DNase, an enzyme which hydrolyses the 
phosphodiester bonds in DNA strands. The remaining RNA was washed three times 
with manufacturers wash buffers and the RNA was eluted in RNase free water, 60µl per 
sample. (Macherey & Nagel 2010). The extraction protocol is illustrated in figure 5.  
 
After the extraction the purity of the samples was measured with Nanodrop 
spectrophotometer and the samples were stored in -80°C freezer. The purity was 
analyzed with RNA concentration ratio from two different wavelengths measured with 
the spectrometer: 280nm/260nm. When the concentration ratio is near 2,10 the RNA is 
considered pure. (Biomedical Genomics 2007) 
 
 
FIGURE 5. RNA extraction protocol 
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4.6 Complementary DNA reverse transcription 
 
Extracted RNA from samples was transcribed to complementary DNA using reverse 
transcriptase enzyme. The reaction was carried out in normal PCR machine. The 
samples were kept on ice during the working procedure. First the samples were diluted 
with RNase free water to achieve a RNA concentration of 1mg/10µl. Every sample had 
a duplicate sample and RNA was pipetted from every two parallel samples into one tube 
to get the desired concentration of 1mg/10µl. Appendix 4 shows the amounts of RNA in 
samples and the amount pipetted to cDNA samples. 
 
Master mix solution was prepared according to work protocol (table 5) and 10µl was 
added to each sample tube. The solution in tubes was spinned down with centrifuged 
and moved to the PCR machine. PCR conditions are listed in table 6. 
 
TABLE 5. Master mix reagents 
Reagent Amount µl (one reaction) 
10x Rt Buffer 2 
25x dNTP mix 0,8 
10x random primers 2 
Reverse transcriptase 1 
RNase inhibitor 1 
H2O 3,2 
 
TABLE 6. PCR run conditions 
Temperature 25°C 37°C 85°C 4°C 
Time 10 min 120 min 5 sec ∞ 
 
After the PCR the samples were stored in -4°C freezer until the q-PCR run.  
 
 
4.7 Quantitative polymerase chain reaction 
 
Before the reaction, half of the cDNA sample volume was diluted 1:3 and this dilution 
was used for the q-PCR reaction. For the characterization of the cell samples various 
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gene markers were used. The markers are listed in table 7 as well as the visualization 
technique that was used. Each gene marker had to be made in separate plates.  
 
TABLE 7. Gene markers used in the study. 
Gene  Visualization technique 
Nanog TaqMan 
OCT3/4 (POU5F1) TaqMan 
 RPLP0 (housekeeping gene) TaqMan 
PPIG (housekeeping gene) SYBR 
Troponin T SYBR 
Nkx2,5 SYBR 
ISL-1 SYBR 
 
 
The master mix solution was a ready-to-use commercial solution. For one sample 7,5µl 
of Master mix was used. 5,75 µl of water and the primers were added to master mix 
solution to get the working solution. 0,75 µl of TaqMan primers or 0,45 of forward and 
reverse SYBR primers  were added. Master mix was pipetted onto 96-well plate, 14 µl 
per well according to premade pipetting charts (figure 6). Water and –RT samples were 
added as controls. –RT is a normal sample from cDNA reverse transcription reaction, 
but it didn’t contain the enzyme and therefore shouldn’t contain any DNA. Each sample 
was made in triplicate for the q-PCR to make sure of successful reaction in case of 
contaminations or accidental pipetting faults. 1 µl of sample was added to each well 
with the master mix and the top of plate was sealed with a plastic sheet cover. The plate 
was centrifuged and placed in the q-PCR machine. The thermal program was premade 
in the machine. Table 8 shows the thermal program of the TaqMan assay and table 9 
shows the SYBR assay.  
 
TABLE 8. Thermal program of q-PCR reaction for TaqMan assay 
Temperature 50 °C 95°C 95°C 60°C 
Time 2 min 10 min 15 sec 1 min 
Cycles 1 1 40 
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TABLE 9. Thermal program of q-PCR reaction for SYBR assay 
Temperature 50 °C 95°C 95°C 60°C 95°C 60°C 95°C 
Time 2 min 10 min 15 sec 1 min 15 sec 1 min 15 sec 
Cycles 1 1 40 1 1 1 
 
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d H2O H7 p.57
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d  -RT h1/12 p.28
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d 0JoHa/25 p.41
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d Reges22d Reges-30d
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d Reges22d Reges-30d
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d Reges22d Reges-30d
0d 0d 0d 0%-22d 0%-22d 0%-22d 10%-22d 10%-22d 10%-22d EB-22d EB-22d EB-22d
13d 13d 13d 0%-30d 0%-30d 0%-30d 10%-30d 10%-30d 10%-30d EB-30d EB-30d EB-30d
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d H2O H7 p.60
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d  -RT h1/12 p.30
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d
0d 13d 0%-22d 10%-22d EB-22d Reges22d 0%-30d 10%-30d EB-30d Reges-30d
 
FIGURE 6. The pipetting chart for samples in q-PCR 
 
After the q-PCR runs the results were analyzed using the relative quantification of gene 
expression data and the 2
- Δ ΔC
T-method. The purpose of q-PCR was to show the changes 
in gene expression from day 0 through days 13 and 22 to day 30. As previously stated, 
Nanog and OCT3/4 are stem cell markers, which means that their expression should be 
high on day 0 samples, when the sample cells were still undifferentiated stem cells. The 
other markers, ISL1, NKX2,5 and Troponin T are cardiac markers and should be 
expressed during and after the differentiation. 
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5 RESULTS 
 
 
5.1 Beating areas  
 
Every media tested in the study yielded beating areas and therefore worked in the 
differentiation of stem cells into cardimyocytes, but the amounts of beating areas and 
they quality varied with each medium. The best percentage of beating areas per attached 
cell colony was achieved with 0% KO-SR hes-medium. The worse medium percentage-
wise was Reges medium, although the differences are very small. The amount of 
beating areas, attached cell colonies and beating percentage for each cell line and 
passage number is illustrated in tables 10, 11 and 12. The overall differentiation results 
are illustrated in table 13 to clarify the results between each medium.  
 
TABLE 10. Differentiation results from H7 cell line 
H7 p.57       
Medium Attached colonies Beating areas Differentiation-% 
0 % 368 113 31 
10 % 338 188 56 
EB 383 138 36 
Reges 390 113 29 
      
H7 p.60     
Medium Attached colonies Beating areas Differentiation-% 
0 % 331 53 16 
10 % 361 35 10 
EB 405 35 9 
Reges 387 20 5 
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TABLE 11. Differentiation results from h1/12 cell line 
h1/12 p.28       
Medium Attached colonies Beating areas Differentiation-% 
0 % 271 38 14 
10 % 264 45 17 
EB 299 52 17 
Reges 289 30 10 
    
h1/12 p.30     
Medium Attached colonies Beating areas Differentiation-% 
0 % 344 75 22 
10 % 488 43 9 
EB 277 38 14 
Reges 409 63 15 
 
TABLE 12. Differentiation results from 0/gG/25 cell line 
0/gG/25 p.41     
Medium Attached colonies Beating areas Differentiation-% 
0 % 398 48 12 
10 % 377 18 5 
EB 332 28 8 
Reges 373 15 4 
      
0/gG/25 p.44    
Medium Attached colonies Beating areas Differentiation-% 
0 % 57 2 4 
10 % 92 2 2 
EB 57  0,0 
Reges 76 2 3 
 
TABLE 13. Overall differentiation results from each medium 
  0 % 10 % EB Reges 
Attached colonies 1769 1920 1753 1924 
Beating areas 329 331 291 243 
Differentiation-% 18,60 17,24 16,60 12,63 
 
The last test for 0/gG/25 p.44 yielded unsatisfactory results, which was caused by the 
strangely small amount of cells attached to the plate at the beginning of differentiation 
procedure. There were only a few attached cell colonies per well which of course made 
it much harder to get beating areas from that cell mass. The differentiation procedure 
was carried out the same way as all the previous ones and despite the results, no 
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contaminations were found from the wells. Because of the low amount of cells, 0/gG/25 
p.44 cell line was not included in the rest of the characterization analysis.  
 
 
5.1.1 Cell morphology and beating character of differentiated cardiomyocytes. 
 
The most interesting effect on the growth and differentiation of the cell lines was with 
0% KO-SR medium. Soon after the medium change on day 15 the beating areas started 
to appear but at the same time the undifferentiated cell mass started to detach from the 
bottom of the wells. As a result on day 22 when beating areas were counted most of the 
cell mass was gone or floating in the medium as dead cell debris, but the beating areas 
were looking really good and beating nicely. With the three other media the cell mass 
on the wells looked normal and healthy, cells started to detach only with 0% KO-SR 
medium. Picture 1 shows this phenomenon with a beating area from 10% KO-SR 
medium as reference.  
 
 
PICTURE 1. Beating areas from day 22 0/gG/25 p.41  
 
The morphology of beating areas was pretty similar with 0% KO-SR- and10% KO-SR-
media. Most beating areas were large ranging from 200 to 1000 µm and their shape was 
mostly roundish. EB- and Reges-media yielded as large beating areas as 0%-and 10% 
KO-SR but also many small beating areas, even areas the size of few cells. There was 
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no distinguishable difference in the shapes of the beating areas between the four test 
media. Picture 2 illustrates good examples of beating areas with EB and Reges media 
from d22 h1/12 p. 30 cell line.  
 
 
PICTURE 2. Beating areas from d22 h1/12 p.30 
 
The rate of beating with 0%-, 10%- and EB-medium was mostly consistent with the 
average beating rate of 30-60 beats/min with few exceptions that are normal in this line 
of research. Out of these three, cells grown in EB medium showed the largest variety in 
the speed of beating. The interesting part was the beating rate acquired with Reges 
medium. This medium caused really unstable beating. Some areas were beating really 
fast and some slower but the most common were the long pauses between beating 
cycles. For example the cells beat about ten times followed by a pause of 30 seconds 
after which another cycle of ten beats followed. These pauses between beatings were 
manifested in all three cell lines and passages but not in every possible beating area. 
 
Beating areas were formed mostly in aggregate formations in the wells, but some 
beating areas were also observed in large vesicles or in the cell floor in as single layer 
beating areas. Picture 3 shows such beating areas. On the right side of picture there are 
two beating areas in EB medium, the black one is an aggregate and the clear one is 
single layer beating area. Beating area formed in a vesicle is on the left side of picture.  
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PICTURE 3. Beating areas from h1/12 p.28 and H7 p.60 
 
 
5.1.2 Dissociated beating areas 
 
The survival of dissociated cells was not thoroughly tested, but from visual observation 
it was clear that most of the dissociated cells did not survive the procedure.  On the first 
day after dissociation there were a large number of dead cells floating in the medium. 
Right side of picture 4 shows some attached cells growing on the plate and multiple 
dead cells floating above them. The survived cells showed a good percentage of beating 
(results are only visual estimations) and the structure of cardiomyocytes was visualized 
from the single beating cells. On the left side of picture 4 is a good example of a single 
cardiomyocyte cell. 
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PICTURE 4. Dissociated cardiomyocytes from h1/12 p.30 cell line 
 
 
5.2 Immunocytochemically stained cells 
 
Each antibody yielded successful results by binding to their target area in each cell line. 
First pair of antibodies, Connexin 43 + α-Actinin showed cardiomyocytes stained red 
with Connexin and Ca2+-channels and Z-disc filaments stained green with α-Actinin, as 
seen in the figure 7 (pictures A2 and A2) which represents every antibody pairs. 
Pictures were not included of every possible cell line, passage and medium, because the 
beating cells were very similar in single cell state. In the second pair of antibodies, 
ventricular MHC stained the ventricular cardiomyocytes with green and Troponin T 
stained all cardiomyocytes with red (B1 and B2.) The last pair of antibodies visualized 
the amount of cardiomyocytes in the well compared to other cell types. Troponin T 
stained the cardiomyocytes red and Vimentin stained other cells green (C1 and C2.) The 
cell nuclei are stained blue in every picture.  
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FIGURE 7. Immunocytochemical staining of cardiomyocytes 
 
 
5.3 RNA extraction 
 
RNA extraction was carried out successfully and almost every sample yielded satisfying 
amounts of RNA. The problems roused with day 0 samples and from differentiated cells 
grown in 0% KO-SR-medium. The RNA concentration in these samples was almost 
consistently two to ten times lower than in other samples. The purity of the RNA was 
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really good, the 260/280 ratio was near 2,10 in most samples, with the same exception 
of day 0- and 0%-samples. Tables 13 and 14 show the RNA concentrations and purities 
from each cell line, media and time points. 
 
TABLE 13. RNA extraction results from first passages cell lines 
RNA extraction H7 p.57 h1/12 p.28 o/gG/25 p.41
Sample µg/µl 260/280 µg/µl 260/280 µg/µl 260/280
d0_1 84,96 1,72 39,6 1,88 31,85 2,1
d0_2 26,14 2,64 20,88 2,48 28,75 2,09
d13_1 114,52 2,14 290,24 2,14 97,73 2,2
d13_2 64,53 2,2 147,09 2,16 45,58 2,18
d22 0%_1 141,7 2,15 188,81 1,89 49,11 2,24
d22 0%_2 131,24 2,02 181,45 2,07 23,11 2,59
d22 10%_1 261,83 2,09 250,81 2,12 234,24 2,16
d22 10%_1 326,1 1,84 192,57 2,12 287,61 2,17
d22 EB_1 226,84 2 168,32 2,08 266,81 2,16
d22 EB_2 274,81 1,95 269,52 2 271,73 2,16
d22 Reges_1 220,12 2,16 109,85 2,1 153,89 2,16
d22 Reges_2 239,7 2,15 193,59 2,09 53,29 1,98
d30 0%_1 24,23 1,76 40,13 2,34 4,46 1,56
d30 0%_2 82,74 1,7 16,55 2,21 2,95 3,19
d30 10%_1 135,29 1,86 289,71 2,15 237,76 2,13
d30 10%_2 188,3 2,12 159,38 2,17 165,85 2,17
d30 EB_1 204,88 2,15 228,66 2,16 250,63 2,15
d30 EB_2 156,6 2,24 175,05 2,14 261,27 2,16
d30 Reges_1 162,28 2,11 219,1 2,17 93,92 2,2
d30 Reges_2 163,06 2,04 159,53 2,18 127,03 2,22  
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TABLE 14. RNA extraction results from second passage cell lines 
RNA extraction H7 p.60   h1/12 p.30 
Sample µg/µl 260/280 µg/µl 260/280 
d0_1 22,28 1,82 11,96 2,34 
d0_2 15,75 2,16  -  - 
d13_1 72,08 2,18 116,14 2,11 
d13_2 75,56 2,18 56,89 2,28 
d22 0%_1 40,05 2,23 12,46 1,95 
d22 0%_2 25,42 2,51 21,37 2,09 
d22 10%_1 59,01 2,17 126,66 2,17 
d22 10%_1 59,17 2,14 265,3 2,16 
d22 EB_1 192,31 2,13 74,39 2,16 
d22 EB_2 282,09 2,15 101,92 2,15 
d22 Reges_1 87,37 2,21 88,97 2,16 
d22 Reges_2 121,56 2,17 60,96 2,2 
d30 0%_1 2,25 1,52 11,79 1,98 
d30 0%_2 1,89 0,96 2,35 2,82 
d30 10%_1 161,5 2,13 123,48 2,15 
d30 10%_2 129,87 2,15 222,64 2,15 
d30 EB_1 193,59 2,13 13,33 2,2 
d30 EB_2 77,82 2,14 238,55 2,15 
d30 Reges_1  -  - 351,27 2,21 
d30 Reges_2  -  - 49,03 2,23 
 
 
5.4 Q-PCR results 
 
Stem cells from tested cell lines and cardiomyocytes differentiated in four different 
media were tested for the gene expression of certain stem cell- and cardiac-specific 
markers using quantitative polymerase chain reaction. The method showed that the 
expression of stem cell markers Nanog and OCT3/4 (POU5F1) was very high in 
undifferentiated cell samples taken in day 0 and close to non-existent in differentiated 
cardiomyocytes. Figure 8 shows the expression of tested markers Nanog and POU5F1. 
The height of bars represents the relative gene expression of the samples in relation to 
each other. The bars are similar in day 0 because the medium is the same in every 
sample at that point; the new test medium was changed only on day 15. The black line 
at the top of the bars represents the error marginal, which comes from combining the 
triplicate samples.  
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The expression of cardiac markers showed more or less the desired gene expression. 
Each marker was expressed much stronger in cardiomyocytes from day 13-, 22- and 30-
samples than in stem cells from day 0 samples. Each day 13 sample is the same, which 
is the reason for identical gene expression bars at day 13. The most distinguishable was 
the results from 0% KO-SR medium. The relative gene expression bar was much higher 
at day 30 samples than in any other of the three media. Figures 9 and 10 show how the 
gene expression increases even ten-fold in day 30 samples in 0%-medium, compared to 
day 22 samples. Similar expression at day 30 did not appear in any other tested media.  
 
Out of the three tested cardiac markers, ISL1expression was the highest in day 13 
samples and NKX2,5 and Troponin T very expressed more in day 22 and 30 samples. 
There were exceptions also, most likely caused by the differences in cell lines and the 
randomness of samples taken for the q-PCR.  
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FIGURE 8. Gene expression of Nanog and POU5F1 (OCT3/4) markers 
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FIGURE 9. Gene expression of ISL1 and NKX2,5 markers 
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FIGURE 10. Gene expression of Troponin T-marker 
 
 
 
In the q-PCR results, there does not appear to be any clear difference between the cell 
lines, whether they were iPS cell lines or not. ISL1 markers shows best this seemingly 
random gene expression of different samples. The same randomness occurs between 
different passages of the same cell line. For example in h1/12 p.28 the expression of 
ISL1 is low on day 22 and 30 Reges samples, but much higher in p.30 samples. Only 
medium that shows constantly high gene expression is 0% KO-SR, in day 30 samples.  
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 6 DISCUSSION 
 
 
In the study a successful differentiation in form of beating areas was acquired with each 
medium, and only a small difference in the differentiation percentage between test 
media was observed. The best medium in this sense was 0%-KO-SR hes medium. The 
results were interesting, because this medium yielded fine beating areas but almost all 
other cell mass detached from the growing plate. This could help the dissociation of 
beating areas considerably in the future, but it could also affect the maturation of 
cardiomyocytes negatively. This study does not show any signs of such effects though.  
A very useful point for future research is that 0%-KO-SR-medium is xeno- and animal 
free and could thus be used in clinical applications.  
 
Media that used serum extracted from animals (EB) and media with serum replacement 
(10% KO-SR hes) worked almost as well as 0%-medium and should not be neglected in 
the research, at least yet. Still, it was good to get similar results as Passier & Co (2005) 
in their article about cardiomyocyte differentiation in serum-free culture. The most 
worrisome was the unstable beating of cells in Reges medium. This kind of beating is 
not desirable for cardiomyocytes, when considering future clinical applications. 
Because the medium reagents are known, and it mostly resembles knockout serum 
replacement formulation, it is fairly easy to guess what reagent caused the instability. 
FGF basic and Activin-A are reagents that have been used for a long time in cardiac 
differentiation, so the possible cause is retinol. It would be interesting to see whether 
Reges would yield similar or completely different results without retinol or modified 
some other way. 
 
It was expected that the H7 control cell line would yield best differentiation results, but 
between iPS cell lines, the one derived from a new-born fibroblasts (h1/12) seemed to 
fare better than patient iPS line (0/gG/25). The reasons for this are numerous and mostly 
unknown and require more research. The obvious decline in the amount of beating areas 
between first and second passages of all cell lines is probably caused by the problems 
faced at Regea with the cell growing plates. The batch of plates used during second 
passages was apparently flawed somehow and could have affected the growth of cells 
negatively. Small calculation errors may have also been made during the microscoping 
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of beating areas, but every plate was counted with the same systematical method 
allowing no bias towards any medium or cell line. The q-PCR results in part also 
confirm the differences between the cell lines, showing slightly different gene 
expression between cells lines with the same medium. 
 
The immunocytochemical staining showed the successful differentiation from each cell 
line and medium and also showed that stem cells differentiated into ventricular and 
atrial cardiomyocytes, as shown in Humpath (2010). The high amount of non-
cardiomyocytes in the beating areas was also visualized with Vimentin-antibody. 
 
RNA yield from commercial RNA extraction kit protocol was good enough for most 
samples. The goal was to acquire 1mg of RNA from the duplicate samples to be used in 
the cDNA reverse transcription. The low amount of RNA in day 0 samples is hard to 
explain, but the loss of most cells in 0%-medium wells was the cause for low RNA 
yield.  All the samples were taken randomly, so some samples may have had much less 
cell growing in the wells. The purity of the samples was good, excluding the previous 
day 0- and 0%-samples. Despite low RNA concentrations, each sample produced 
enough cDNA for q-PCR analysis.  
  
Quantitative PCR tested the samples for their expression of certain genes typical for 
either stem cells or cardiomyocytes. Results were very successful for both markers. As 
described by Sperger & Co (2003), the stem cell markers Nanog and OCT3/4 were 
clearly expressed only in day 0 samples, except for the H7 p.60 day 30 sample in 0%-
medium, where Nanog is expressed higher than in day 0 samples. The same sample 
expresses cardiac markers also very highly, so it may be that the sample for Nanog 
analysis was contaminated.  
 
The expression of cardiac markers ISL1, NKX2,5 and Troponin T in differentiated 
cardiomyocytes was higher than in stem cell samples, as expected. Cai & Co (2003) 
described ISL1 as a cardiac mesoderm marker, so the gene expression was expected to 
be highest in the early stage of differentiation, in this case on day 13. The results 
confirmed this with ISL1 expression being highest in day 13 in most cell lines. The 
other markers, NKX2,5 and Troponin T provided higher gene expression in older 
samples as suggested by Megy & Co (2002) and Schwartz & Co (1999). 
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 Particularly interesting were the results from 0% KO-SR medium. By day 30, the 
cardiomyocytes seemed to be the most matured in this medium, when comparing the 
gene expressions of all three tested cardiac markers to other test media. This suggests 
that 0% KO-SR is the best suited for long term differentiation protocol. The unusually 
high gene expression may be explained with the low yield of RNA from 30 day samples 
in 0% KO-SR-medium. The starting material was small, but contained more 
cardiomyocytes than any other media-sample, because other than beating cells had 
detached from the wells. The RNA material was amplified as cDNA before q-PCR and 
because other samples had more RNA from non-cardiomyocytes, the relative amount of 
cardiomyocyte cDNA was higher in day 30 0% KO-SR samples.  
 
The results from q-PCR are indicative about the cardiac differentiation, but the 
technique is not absolutely accurate. It would have been interesting to verify the q-PCR 
results with protein analysis, using western blot technique to accurately identify target 
proteins from sample cardiomyocytes. Western blot as an additive analysis is 
recommended in the future research.  
 
This study was done to test the cardiac differentiation capabilities of four media: 0% 
KO-SR hes, 10% KO-SR hes, EB-medium and Reges-medium. Out of these four 10% 
and EB medium worked fine in differentiation, producing nicely beating 
cardiomyocytes with the desired gene expressions. Reges-medium worked also in 
differentiation, but the instability in the beating of cells makes it undesirable for 
research at least until the cause is better know. Based on the results of this study the 
medium best suited for cardiomyocyte differentiation seems to be 0% KO-SR hes-
medium. Not only did it produce the most beating areas with good morphology and 
beating, but the maturation of cardiomyocytes in the late stage of differentiation was 
much better than with other media.  
 
One aim of the study was also to find a cheaper medium for cardiac differentiation in 
Regea. Since 0% KO-SR hes is the most plain of the media used in the study, it’s also 
the cheapest. And as the results suggest this medium as the most suitable for 
cardiomyocyte differentiation, the other aim was also fulfilled. Based on these results 
this medium definitely deserves additional research, perhaps on even older than 30-
days-old cardiomyocytes.  
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The understanding and optimization of the mechanism of cardiomyocyte differentiation 
from pluripotent stem cells is one step towards the solution of treating cardiac diseases. 
The introduction of induced pluripotent stem cells helped study cardiac diseases but the 
whole differentiation mechanism is still not clear enough to study clinical applications. 
With the knowledge of this study, the understanding of certain effects of culture media 
and reagents in the differentiation characteristics of cardiomyocytes can be used in 
additional studies to improve cardiomyocyte differentiation.  
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LIST OF REAGENTS USED IN CARDIOMYOCYTE  APPENDIX 1: 1 (2) 
 DIFFERENTIATION MEDIA  
 
0% KO-SR hes 
 Reagent Amount in 50ml 
KO-DMEM 48,75ml 
NEAA 0,5ml 
Glutamax 0,5ml 
Pen/Strep 0,25ml 
b-mercaptoethanol 97,5µl 
  10% KO-SR hes 
 KO-SR 5ml 
KO-DMEM 43,75ml 
NEAA 0,5ml 
Glutamax 0,5ml 
Pen/Strep 0,25ml 
b-mercaptoethanol 97,5µl 
  EB-medium 
 KO-DMEM 39,75ml 
FBS 10ml 
NEAA 0,5ml 
Glutamax 0,25ml 
Pen/Strep 0,25ml 
 
Abbreviations: 
NEAA: non-essential amino acids 
FBS: Fetal bovine serum 
Pen/Strep: Penicillin and Streptomycin 
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APPENDIX 1: 2 (2) 
 
  
Reges-medium   
Component Concentration mg/l 
Amino acids   
Glycine 53 
L-histidine 183 
L-isoleusine 615 
L-methionine 44 
L-phenylalanine 336 
L-proline 600 
L-hydroxyproline 15 
L-serine 162 
L-threonine 425 
L-tryptophan 82 
L-tyrosine 84 
L-valine 454 
Vitamins   
Thiamine 9 
Retinol 0,5 
Antioxidants   
Glutathione 1,5 
Ascorbic acid 50 
Proteins   
Human serum albumin  10000 
Transferrin 8 
FGF basic 0,008 
Activin A 0,005 
Trace elements   
Trace element B 1 / 1000 
Trace element C 1 / 1000 
Selenium 0,00001 
Other components   
Non-essential amino acids 1 % 
L-glutamine 2mM 
b-mercaptoethanol 0,14mM 
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LIST OF DISSOCIATION BUFFER REAGENTS  APPENDIX 2 
Dissociation 
buffers       
Reagent 
Buffer 1 
(100ml) 
Buffer 2 
(100ml) 
Buffer 3 
(100ml) 
NaCl 12ml (1M) 12ml (1M)  - 
CaCl2      - 
K2HPO4  -  3µ  (1M) 3ml (1M) 
KCl 0,54,l (1M) 0,54ml (1M) 8,5ml (1M) 
Na2ATP  -  - 2mmol/L 
MgSO4 0,50ml (1M) 0,50ml (1M) 0,50ml (1M) 
EGTA  -  -  0,1ml (1M) 
Na Pyruvaat 0,50ml (1M) 0,50ml (1M) 0,50ml (1M) 
Glucose 2ml (1M) 2ml (1M) 2ml (1M) 
Creatine  -  - 5ml (1M) 
Taurine 20 ml (1M) 20 ml (1M) 20 ml (1M) 
Collagenase A  - 1mg/ml  -  
HEPES 1ml (1M) 1ml (1M)  -  
pH corr. NaOH NaOh  -  
pH 6,9 6,9 7,2 
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LIST OF ANTIBODIES AND THEIR DILUTIONS  APPENDIX 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary Antibodies + 
wavelength (nm) Origin Dilution 
Connexin 43  Rabbit 1 / 1000 
α-actinin Mouse 1 / 500  
MHC Mouse 1 / 100  
Troponin T Goat 1 / 500 
Vimentin Rabbit 1/1 
Troponin T Mouse 1 / 500 
      
Secondary antibodies Origin Dilution 
anti-mouse Alexa 568 Donkey 1 / 300 
anti-rabbit Alexa 488 Donkey 1 / 300 
anti-mouse Alexa 488 Donkey 1 / 300 
anti-goat Alexa 568 Donkey 1 / 300 
anti-rabbit Alexa 488 Donkey 1 / 300 
anti-mouse Alexa 568 Donkey 1 / 300 
49 
 
RNA CONCENTRATIONS   APPENDIX 4: 1 (2) 
 
 
 
The RNA concentrations and amounts of samples pipetted for cDNA reverse 
transcription reaction. The total volume of 10µl was filled with RNase-free water.  
 
 
Sample H7 p.57 H7 p.60 h1/12 p.28 h1/12 p.30
µg/µl sample µl µg/µl sample µl µg/µl sample µl µg/µl sample µl
d0_1 84,96 5 22,28 5 39,6 10 11,96 10
d0_2 26,14 5 15,75 5 20,88 0
d13_1 114,52 7 72,08 5 290,24 2 116,14 7
d13_2 64,53 3 75,56 5 147,09 3 56,89 3
d22 0%_1 141,7 4 40,05 10 188,81 2,4 12,46
d22 0%_2 131,24 4 25,42 181,45 3 21,37 10
d22 10%_1 261,83 2 59,01 5 250,81 2 126,66 4
d22 10%_1 326,1 1,5 59,17 5 192,57 2,6 265,3 2
d22 EB_1 226,84 2 192,31 3 168,32 2,7 74,39 1
d22 EB_2 274,81 2 282,09 1,5 269,52 2 101,92 9
d22 Reges_1 220,12 2,3 87,37 3 109,85 3 88,97 10
d22 Reges_2 239,7 2 121,56 6 193,59 4 60,96
d30 0%_1 24,23 5 2,25 5 40,13 10 11,79 10
d30 0%_2 82,74 5 1,89 5 16,55 0 2,35
d30 10%_1 135,29 3,2 161,5 3 289,71 2 123,48 4,5
d30 10%_2 188,3 3 129,87 4 159,38 2,7 222,64 2
d30 EB_1 204,88 2,5 193,59 3 228,66 2 13,33
d30 EB_2 156,6 3 77,82 5,5 175,05 3 238,55 4,2
d30 Reges_1 162,28 3,2 219,1 2 351,27 3
d30 Reges_2 163,06 3 159,53 3,5 49,03 0  
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     APPENDIX 4: 2 (2) 
Sample 0/gG/25 p.41
µg/µl sample µl
d0_1 31,85 5
d0_2 28,75 5
d13_1 97,73 5
d13_2 45,58 5
d22 0%_1 49,11 5
d22 0%_2 23,11 5
d22 10%_1 234,24 2
d22 10%_1 287,61 2
d22 EB_1 266,81 2
d22 EB_2 271,73 1,7
d22 Reges_1 153,89 5
d22 Reges_2 53,29 4
d30 0%_1 4,46 5
d30 0%_2 2,95 5
d30 10%_1 237,76 2
d30 10%_2 165,85 3,2
d30 EB_1 250,63 2
d30 EB_2 261,27 2
d30 Reges_1 93,92 5,5
d30 Reges_2 127,03 4  
 
 
 
